Search
for
Sort by
Research 241–270 of 1000+
- Clinical pathology in equine dermatology
- Effectiveness of Exosome Treatment in Androgenetic Alopecia: Outcomes of a Prospective Study
- Dermatologic care of the transgender patient - eScholarship
- Nails and hair
- Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata
- Gender differences in skin: A review of the literature
- Dermoscopy of skin infestations and infections (entomodermoscopy) – Part I: dermatozoonoses and bacterial infections
- Alopecia areata – Current understanding and management
- Psychotropic Medications and the Skin
- Generalized Alopecia with Vasculitis-Like Changes in a Dog with Babesiosis
- A CLINICOEPIDEMIOLOGICAL STUDY OF CUTANEOUS MANIFESTATIONS IN GERIATRIC AGE GROUP
- A CLINICAL STUDY OF MUCOCUTANEOUS MANIFESTATIONS OF HIV
- Response to Corona-Rodarte et al.’s “Pressure alopecias: a review”
- Use of Botulinum Toxin for Androgenic Alopecia: A Systematic Review
- Parasitic dermatitis in dogs: A literature review of clinical and diagnostic aspects and treatment approaches
- Tinea capitis in Older Adults: A Neglected and Misdiagnosed Scalp Infection—A Systematic Review of Reported Cases
- Botulinum toxin therapy for androgenetic alopecia: From mechanistic insights to clinical applications
- Granuloma annulare with alopecia areata in a 6-year-old girl: a case report
- Some skin affection in New Valley Governorate
- Autologous stromal vascular fraction cells combined with platelet-rich plasma for androgenic alopecia treatment: a case series
- JAK Inhibitors for Treatment of Alopecia Areata
- Hair follicle is a target of stress hormone and autoimmune reactions
- Topical ketoconazole: a systematic review of current dermatological applications and future developments
- Adolescent hair loss
- Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone
- Analysis of the scalp of women with AIDS subjected to autopsy: epithelial, follicular, and immunologic aspects
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Treatment of MSCs with Wnt1a-conditioned medium activates DP cells and promotes hair follicle regrowth